![]() |
市場調查報告書
商品編碼
1422650
神經復健設備市場 - 按產品類型(神經機器人、穿戴式裝置、BCI、非侵入性刺激器)、按應用(中風、多發性硬化症、帕金森氏症、脊髓損傷)、依最終用途(醫院、專科診所)和預測,2024 年-2032Neurorehabilitation Devices Market-By Product Type (Neurorobotics, Wearable Devices, BCI, Non-Invasive Stimulators), By Application (Stroke, MS, Parkinsons Disease, Spinal Cord Injury), By End-use (Hospitals, Specialty Clinics) & Forecast, 2024-2032 |
預計從 2024 年到 2032 年,神經復健設備市場規模將成長 13.4% 以上。神經系統疾病的盛行率不斷上升,加上人口老化,正在推動對有效復健解決方案的需求。快速的技術進步,包括機器人輔助設備和基於虛擬實境的療法,正在提高神經復健的功效。例如,2023年2月,數位神經治療解決方案提供商MindMaze推出了Izar,這是首款針對手部運動功能受損患者的智慧週邊,獲得美國FDA批准並獲得歐盟CE認證。歐洲聯盟。
人們對神經系統疾病早期介入和復健益處的認知不斷提高,這將推動神經復健設備的採用。此外,政府支持性措施的存在有利於個人化和家庭復健解決方案的整合。持續進行的專注於神經復健設備創新的研發活動將進一步推動產業成長。
神經復健設備市場按產品類型、應用、最終用途和地區分類。
根據產品類型,預計 2024 年至 2032 年穿戴式設備領域的行業佔有率複合CAGR為 13.7%。這一成長可歸因於攜帶式和方便用戶使用型神經復健解決方案的日益普及。穿戴式裝置提供持續監測和個人化復健體驗,以增強患者參與度。此外,將復健融入日常活動的便利性以及先進感測器技術的整合將推動產品需求。
由於脊髓損傷發生率不斷上升,脊髓損傷應用領域的神經復健設備市場從 2024 年到 2032 年的CAGR可能達到 13%。先進的神經復健設備有助於功能恢復、肌肉強化和改善活動能力,進一步有助於提高脊髓損傷患者的復健效果。
從地區來看,亞太地區神經復健設備產業預計 2024 年至 2032 年間CAGR將達到13.7%。這種成長可歸因於神經系統疾病盛行率的增加、人口老齡化的加劇以及對先進對復健解決方案的認知不斷提高。此外,醫療保健基礎設施的改善和技術先進的神經復健設備的日益採用將推動區域市場的擴張。
Neurorehabilitation devices market size is projected to expand at over 13.4% from 2024 to 2032. The increasing prevalence of neurological disorders coupled with the growing aging population is fueling the demand for effective rehabilitation solutions. The rapid technological advancements, including robotic-assisted devices and virtual reality-based therapies are leading to enhanced efficacy of neurorehabilitation. For instance, in February 2023, a provider of digital neuro-therapeutics solutions, MindMaze, launched Izar, a first-of-its-kind smart peripheral for patients with impaired hand motor function, approved by the U.S. FDA and CE-marked from the EU.
The rising awareness about the benefits of early intervention and rehabilitation in neurological conditions will drive the adoption of neurorehabilitation devices. Additionally, the presence of supportive government initiatives is favoring the integration of personalized and home-based rehabilitation solutions. The ongoing R&D activities, focusing on innovations in neurorehabilitation devices will further boost the industry growth.
The neurorehabilitation devices market is segregated into product type, application, end-use, and region.
Based on product type, the industry share from the wearable devices segment is projected to witness 13.7% CAGR from 2024 to 2032. The growth can be attributed to the increasing adoption of portable and user-friendly neurorehabilitation solutions. Wearable devices offer continuous monitoring and personalized rehabilitation experiences for enhancing patient engagement. Moreover, the convenience of incorporating rehabilitation into daily activities and the integration of advanced sensor technologies will fuel the product demand.
Neurorehabilitation devices market from the spinal cord injury application segment may strike a 13% CAGR from 2024 to 2032, owing to the rising incidences of spinal cord injuries. Advanced neurorehabilitation devices help in functional recovery, muscle strengthening, and improving mobility, further contributing to enhanced rehabilitation outcomes for individuals with spinal cord injuries.
Regionally, the Asia Pacific neurorehabilitation devices industry is projected to expand at 13.7% CAGR between 2024 and 2032. The growth can be ascribed to the increasing prevalence of neurological disorders, growing aging population, and rising awareness about advanced rehabilitation solutions. Furthermore, the improvements in healthcare infrastructure and the increasing adoption of technologically advanced neurorehabilitation devices will drive the regional market expansion.